PDS Biotechnology Corp - ESG Rating & Company Profile powered by AI
If you work at PDS Biotechnology Corp and you would like to use your Sustainability rating, please get in touch. This page contains a zero-cost Environmental, Social and Governance analysis covering PDS Biotechnology Corp. Browse to the bottom of the webpage for potential risks for PDS Biotechnology Corp based on sector, geography and size.
PDS Biotechnology Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.0; made up of an environmental score of 4.0, social score of 4.8 and governance score of 3.2.
4.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
989 | Spectrum Pharmaceuticals Inc | 4.1 | High |
989 | Tricida Inc | 4.1 | High |
1004 | PDS Biotechnology Corp | 4.0 | High |
1004 | Can B Corp | 4.0 | High |
1004 | CLS Holdings USA Inc | 4.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does PDS Biotechnology Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes PDS Biotechnology Corp report the average age of the workforce?
Sign up for free to unlockDoes PDS Biotechnology Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose cybersecurity risks?
Sign up for free to unlockDoes PDS Biotechnology Corp offer flexible work?
Sign up for free to unlockDoes PDS Biotechnology Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PDS Biotechnology Corp conduct supply chain audits?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PDS Biotechnology Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose water use targets?
Sign up for free to unlockDoes PDS Biotechnology Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid PDS Biotechnology Corp have a product recall in the last two years?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose incidents of discrimination?
Sign up for free to unlockDoes PDS Biotechnology Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PDS Biotechnology Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose parental leave metrics?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes PDS Biotechnology Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PDS Biotechnology Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PDS Biotechnology Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose its waste policy?
Sign up for free to unlockDoes PDS Biotechnology Corp report according to TCFD requirements?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose energy use targets?
Sign up for free to unlockDoes PDS Biotechnology Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PDS Biotechnology Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PDS Biotechnology Corp
These potential risks are based on the size, segment and geographies of the company.
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.